Search and analyze individual stocks with comprehensive metrics
Pfizer Ltd
Fundamental Score
Pfizer Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of PFIZER across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (16.40%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (21.62%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (31.81%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (99.16x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Cash Generation (₹2429.75 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (63.92%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Limited Growth History (1.18% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Earnings Growth (4.68% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (4.68% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Loading Peer Comparison
Finding companies in the Pharmaceuticals sector...
Financial Statements
Comprehensive financial data for Pfizer Ltd
About PFIZER
Business Overview
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
Company Details
Key Leadership
Corporate Events
Latest News
PFIZER Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Pfizer Ltd (PFIZER)?
As of 14 Jan 2026, 11:01 am IST, Pfizer Ltd (PFIZER) is currently trading at ₹4819.60. The stock has a market capitalization of ₹22.74K (Cr).
Is PFIZER share price Overvalued or Undervalued?
PFIZER is currently trading at a P/E ratio of 32.18x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Pfizer Ltd share price?
Key factors influencing PFIZER's price include its quarterly earnings growth (Sales Growth: 9.13%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Pfizer Ltd a good stock for long-term investment?
Pfizer Ltd shows a 5-year Profit Growth of 4.68% and an ROE of 16.40%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.01 before investing.
How does Pfizer Ltd compare with its industry peers?
Pfizer Ltd competes with major peers in the Pharmaceuticals. Investors should compare PFIZER's P/E of 32.18x and ROE of 16.40% against the industry averages to determine its competitive standing.
What is the P/E ratio of PFIZER and what does it mean?
PFIZER has a P/E ratio of 32.18x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹32 for every ₹1 of annual earnings.
How is PFIZER performing according to Bull Run's analysis?
PFIZER has a Bull Run fundamental score of 55/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does PFIZER belong to?
PFIZER operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Pfizer Ltd.
What is Return on Equity (ROE) and why is it important for PFIZER?
PFIZER has an ROE of 16.40%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Pfizer Ltd generates profits from shareholders' equity.
How is PFIZER's debt-to-equity ratio and what does it indicate?
PFIZER has a debt-to-equity ratio of 0.01, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is PFIZER's dividend yield and is it a good dividend stock?
PFIZER offers a dividend yield of 0.70%, which means you receive ₹0.70 annual dividend for every ₹100 invested.
How has PFIZER grown over the past 5 years?
PFIZER has achieved 5-year growth rates of: Sales Growth 1.18%, Profit Growth 4.68%, and EPS Growth 4.68%.
What is the promoter holding in PFIZER and why does it matter?
Promoters hold 63.92% of PFIZER shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is PFIZER's market capitalization category?
PFIZER has a market capitalization of ₹22739 crores, placing it in the Large-cap category.
How volatile is PFIZER stock?
PFIZER has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for PFIZER?
PFIZER has a 52-week high of ₹N/A and low of ₹N/A.
What is PFIZER's operating profit margin trend?
PFIZER has a 5-year average Operating Profit Margin (OPM) of 31.81%, indicating the company's operational efficiency.
How is PFIZER's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 9.13% and YoY Profit Growth of 19.37%.
What is the institutional holding pattern in PFIZER?
PFIZER has FII holding of 2.60% and DII holding of 17.11%. Significant institutional holding often suggests professional confidence in the stock.